Success Metrics

Clinical Success Rate
78.9%

Based on 56 completed trials

Completion Rate
79%(56/71)
Active Trials
12(12%)
Results Posted
59%(33 trials)
Terminated
15(15%)

Phase Distribution

Ph phase_1
9
9%
Ph not_applicable
16
16%
Ph phase_2
29
29%
Ph phase_3
19
19%
Ph phase_4
20
20%
Ph early_phase_1
2
2%

Phase Distribution

11

Early Stage

29

Mid Stage

39

Late Stage

Phase Distribution95 total trials
Early Phase 1First-in-human
2(2.1%)
Phase 1Safety & dosage
9(9.5%)
Phase 2Efficacy & side effects
29(30.5%)
Phase 3Large-scale testing
19(20.0%)
Phase 4Post-market surveillance
20(21.1%)
N/ANon-phased studies
16(16.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.7%

56 of 76 finished

Non-Completion Rate

26.3%

20 ended early

Currently Active

12

trials recruiting

Total Trials

100

all time

Status Distribution
Active(14)
Completed(56)
Terminated(20)
Other(10)

Detailed Status

Completed56
Terminated15
unknown10
Recruiting7
Withdrawn5
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
100
Active
12
Success Rate
78.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.1%)
Phase 19 (9.5%)
Phase 229 (30.5%)
Phase 319 (20.0%)
Phase 420 (21.1%)
N/A16 (16.8%)

Trials by Status

unknown1010%
completed5656%
not_yet_recruiting22%
withdrawn55%
recruiting77%
active_not_recruiting55%
terminated1515%

Recent Activity

12 active trials
Showing 5 of 100
not_yet_recruitingphase_2

Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With Sepsis

NCT07572552
active_not_recruitingphase_2

A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

NCT04929379
active_not_recruitingphase_3

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

NCT01320345
active_not_recruitingphase_2

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

NCT06174402
recruitingphase_3

Fenofibrate in Primary Biliary Cholangitis: a Real World Study

NCT06755151
View all 100 trials

Clinical Trials (100)

Showing 20 of 100 trialsScroll for more
NCT07572552Phase 2

Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With Sepsis

Not Yet Recruiting
NCT04929379Phase 2

A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

Active Not Recruiting
NCT01320345Phase 3

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

Active Not Recruiting
NCT06174402Phase 2

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

Active Not Recruiting
NCT06755151Phase 3

Fenofibrate in Primary Biliary Cholangitis: a Real World Study

Recruiting
NCT07296458Phase 3

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

Recruiting
NCT06591455Early Phase 1

A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

Completed
NCT04661358Phase 3

Fenofibrate for Prevention of DR Worsening

Recruiting
NCT05514119Phase 2

A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation

Terminated
NCT06191133Phase 1

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

Recruiting
NCT06155331Phase 2

Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Completed
NCT07104201Early Phase 1

Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

Recruiting
NCT06858332

Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

Recruiting
NCT06365424Phase 2

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

Recruiting
NCT05781698Phase 2

Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis

Completed
NCT06623539Phase 2

Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease

Active Not Recruiting
NCT05080192

Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate

Completed
NCT06451900Phase 4

Role of Fenofibrate in Neonatal Jaundice

Completed
NCT06346743Phase 2

Comparison of Effects of Fenofibrate Adjuvant Therapy Versus Conventional Phototherapy in Neonatal Jaundice.

Not Yet Recruiting
NCT04907084Phase 2

Serine and Fenofibrate Study in Patients With MacTel Type 2

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
100